Norson Biotechnology is based in Shandong, China. It has raised $71M in total funding. Latest round: IPO. Backed by 华金投资, OrbiMed, 乾道基金.
Norson Biotechnology is based in Shandong, China. Norson Biotechnology has raised $71M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is an IPO announced in December 2022. The round record for Norson Biotechnology runs through 2022; nothing later has been disclosed. Investors on record include 华金投资, OrbiMed, 乾道基金, 吉富创投, Guotou Chuangye, 阳光保险 and 3 others. 9 distinct backers are named across the disclosed rounds.
Norson Biotechnology totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shandong below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026